http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2013977-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_974afb8a48aa9d88aef0794f28dce72a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-24 |
| filingDate | 1990-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5606b126a8450b831b699ee05ea75337 |
| publicationDate | 1990-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2013977-A1 |
| titleOfInvention | Mebeverine dosage form |
| abstract | MEBEVERINE DOSAGE FORM ABSTRACT OF THE DISCLOSURE The present invention involves pharmaceutical compositions for the peroral administration of mebeverine comprising a safe and effective amount of mebeverine, and a pharmaceutically-acceptable carrier which comprises means for attaining the transport of the mebeverine through the gastrointestinal tract of the patient to its lower part and means for releasing the mebeverine in the lumen of the lower gastrointestinal tract. |
| priorityDate | 1989-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.